8月8日，Hinge Health盘中上涨9.84%，报87.96美元/股，成交额9241.62万美元。消息面上，公司此前发布Q2财报，营收2.13亿美元大幅超出市场预期的2.01亿美元，同比增长53%；同时全年营收指引上调至8.56亿至8.60亿美元，远高于分析师一致预期的8.22亿美元。Q3营收指引2.23亿至2.25亿美元同样显著高于预期的2.12亿美元。
此外，Morgan Stanley将Hinge Health目标价由108美元上调至117美元，维持增持评级，机构一致目标价均价为100.67美元。强劲的业绩表现及超预期指引持续推动市场对公司成长前景的乐观预期。
Hinge Health是一家AI驱动的数字肌肉骨骼护理平台，通过可穿戴设备和专业临床团队提供从急性损伤到术后康复的全流程服务，致力于改善会员健康结果并为客户降低成本。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.